Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy

Lignende værker

• Change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinoma
  af: Anouk W.M.A. Schaeffers, et al.
  Udgivet: (2025-06-01)
• The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis
  af: Huiskamp, Laura F. J., et al.
  Udgivet: (2020)
• Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
  af: Shimada, Rie, et al.
  Udgivet: (2018)
• The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy
  af: Huiskamp, L. F. J., et al.
  Udgivet: (2020)
• Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
  af: Devleena,, et al.
  Udgivet: (2010)